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ABSTRACT
The cytoplasmic polyadenylation element
binding-protein (CPEB) is an RNA-binding protein
that participates in translational control. CPEB2,
CPEB3 and CPEB4 are paralog proteins very
similar among themselves referred as the CPEB2
subfamily. To gain insight into common mecha-
nisms of regulation of the CPEB2 subfamily tran-
scripts, we looked for putative cis-acting elements
present in the 30-UTRs of the three paralogs.
We found different families of miRNAs predicted
to target all subfamily members. Most predicted
target sites for these families are located in
paralog positions suggesting that these putative
regulatory motifs were already present in the ances-
tral gene. We validated target sites for miR-92
and miR-26 in the three paralogs using mutagenesis
of miRNA-binding sites in reporter constructs
combined with over-expression and depletion
of miRNAs. Both miR-92 and miR-26 induced
a decrease in Luciferase activity associated to
a reduction in mRNA levels of the reporter con-
structs. We also showed that the endogenous
miRNAs co-regulate CPEB2, CPEB3 and CPEB4
transcripts, supporting our hypothesis that these
genes have a common regulatory mechanism
mediated by miRNAs. We also suggest that the
ancestral pattern of miRNA-binding motifs was
maintained throughout the generation of highly
conserved elements in each of the 30-UTRs.
INTRODUCTION
The 30-untranslated regions (30-UTRs) of mRNAs play
a central role in the regulation of gene expression
in higher eukaryotes. Different cis-acting elements
within the 30-UTRs can be recognized by a number
of proteic or ribonucleoproteic complexes that can affect
the stability, translational activity and/or localization
of the mRNAs (1). In vertebrates the cytoplasmic
polyadenylation element (CPE) of consensus UUUUUA
U is one of the best-characterized sequences within the
30-UTRs known to participate in the translational activa-
tion of mRNAs (2). This element, ﬁrst studied in Xenopus
laevis oocyte maturation and later found in other verte-
brates including mammals, is recognized by the CPE
binding-protein (CPEB). The interaction takes place in
the cytoplasm and is responsible for the recruitment of
a well-described proteic complex that determines the
length of the polyA tail of the mRNAs that have the
element [for a review, see (2)]. The length of the PolyA
tail correlates with the translational activity of the mRNA
(3). In general, translationally dormant mRNAs have
short polyA tails while translationally active mRNAs
have more elongated ones.
CPEB is the founding member of a family of
RNA-binding proteins well conserved in vertebrates. All
members of the family contain an N-terminal unstruc-
tured region followed by two RNA recognition motifs
and a zinc-ﬁnger domain towards the carboxy-terminal
end of the protein. The protein directly interacts with
the CPE through its nucleic-acid-binding domains
(4) and interacts with other proteins through the
N-terminal regulatory region (2). The other members of
the CPEB family in tetrapods, CPEB2, CPEB3 and
CPEB4, are very similar at the amino acid sequence of
their RNA-binding domains (5) and are referred as
the CPEB2 subfamily. Since the three members of the
subfamily are present in humans and xenopus
the paralogs duplicated before the divergence of the
lineages. As CPEB, the CPEB2 subfamily members
participate in translational regulation although their rec-
ognition elements are different from the CPE (6). All
members of the family are abundantly expressed in the
brain (5).
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RNA-binding proteins directly interact with mRNAs
and regulate their expression. However, mRNA regulation
can be also mediated through small RNAs, in particular
microRNAs (miRNAs). These small RNAs, 21- to 23-nt
long, are present in all higher eukaryotes (7). In animals,
they inhibit translation or promote degradation of their
target mRNAs by imperfectly binding to their 30-UTRs
(8). Most of the miRNAs speciﬁcity in animals is given
by nt 2–7, also known as the miRNA seed sequence (9).
miRNAs are encoded in the genome and some of them
can be grouped in families due to their sequence
similarity. Some families, such as the let-7 family, are
present in all animals. miRNAs are known to play a
central role in a number of key cellular processes such as
cellular differentiation (10). Also, dysregulation of the ex-
pression of miRNAs has been associated with several
pathologies (11). One of the best-studied cases is the
over-expression of the miR-17 92 cluster in certain
forms of cancer (12).
Given the high degree of conservation of many abun-
dantly expressed miRNAs different algorithms have been
developed to predict target sites in conserved mRNAs
(13). The completion during the last decade of several
genome-sequencing projects of different phyla made
possible to evaluate the conservation throughout evolu-
tion of different cis-acting elements in regulatory
regions. For example, most of the miRNAs prediction
programs essentially check the conservation of motifs
complementary to seed sequences in ortholog 30-UTRs.
As a result from these studies it has been suggested that
many miRNAs can target several hundred messengers.
Moreover, most 30-UTRs have miRNAs target sites (14)
underscoring the importance of this regulatory mechan-
ism. In this way, different miRNAs can target the same
transcript and, conversely, different mRNAs can
be regulated by the same miRNA.
Given the high similarity of the CPEB2 subfamily
members, they might have partially overlapping functions.
Additionally, as they also have an overlapping expression
pattern, they are probably regulated in a similar fashion.
For example, all of the subfamily transcripts could be
simultaneously bound and regulated by a particular set
of miRNAs. To evaluate this hypothesis, we looked for
predicted targets for miRNAs present in CPEB2, CPEB3
and CPEB4 mRNAs. Using reporter constructs,
we validated binding sites for miR-92 and miR-26 in the
three paralogs. Both miRNAs regulate the expression
of the reporter constructs by reducing mRNA levels.
Depletion of miR-92 alone also induces a modest
increase in the levels of the endogenous transcripts.
However, depletion of the miRNAs corresponding to
the different families that are predicted to co-regulate
the transcripts shows a more robust regulation of
the endogenous genes. Our results show that these genes
have a common regulatory mechanism mediated by
miRNAs. We suggest that this mechanism is evolutionary
conserved and it was already functional before
the generation of highly conserved elements in the
30-UTRs.
MATERIALS AND METHODS
Bioinformatics
We obtained from the UCSC genome browser web site
[http://genome.ucsc.edu/; (15)] the windows depicting the
mapping of the last exons of CPEB2, CPEB3 and CPEB4
RefSeq transcripts (16) together with the conservation
plots of the genomic regions across different vertebrates.
To obtain the frequency of 30-UTRs with different pre-
dicted target sites, we analyzed the Supplementary Data
from Lewis et al. (17). We considered that a 30-UTR is
targeted when it has at least one conserved sequence com-
plementary to the seed sequence of any miRNA family.
To determine the position of the predicted targets in the
30-UTRs, we followed the TargetScanS rules (17) and
mapped each position using multiple alignments
of the 30-UTRs. We did the multiple alignments with the
PipMaker program [http://bio.cse.psu.edu/; (18)] under
default parameters. In the case of the human CPEB
paralogs the ﬁnal alignment was manually curated due
to the low similarity among the sequences.
We downloaded the ESTs mapping to the whole CPEB3
30-UTR from the UCSC genome browser. We clustered
those with sequences ﬁnishing within a range of 5nt
from each other. An EST cluster mapping at position
 2990 from the stop codon was generated around
an A-rich sequence encoded in the genome and was
excluded from the analysis because it might have been
generated by oligo dT miss-priming.
Cell culture
We maintained all cells lines used (K562, CaSKI,
GM00637, HACAT, Hep3B, HEK293T, HeLa,
SK-N-BE, T98G, MCF-7, U2OS and SA02) at 37 Ci n
an incubator with a humidiﬁed atmosphere and a 5.5%
concentration of CO2. We grew the cells in Dulbecco0s
Modiﬁed Eagle Medium with GlutaMAX, D-Glucose and
Pyruvate,supplementedwith10%offetalcalfserum(FCS)
and 100mg/ml of Normicin as an antibiotic/anti-mycotic.
We plated regularly passed cells 24h before transfection.
We transfected the cell using Lipofectmine2000 as a trans-
fection reagent following the manufacturers instructions.
We transfected the cells when they were 90% conﬂuent.
WechangedtheculturemediumtoOptimemsupplemented
with 10% FCS during transfections.
Constructs
To clone the different 30-UTRs sections, we ampliﬁed the
regions of interest by PCR from human genomic DNA.
We sub-cloned the ampliﬁcation products inside the pUC
vector and examined the presence of undesired mutations
by sequencing. We used the following sets of primers:
CPEB2 WT dir and rev to amplify CPEB2 WT; CPEB3
WT dir and rev to amplify CPEB3 WT; and CPEB4 WT
dir and rev to amplify CPEB4 WT (for the primer’s
sequences see Supplementary Table S1). To generate the
mutated constructs, we ampliﬁed these plasmids with
mutated primers. Next, we treated the ampliﬁcations
with DpnI to digest the original wild-type template
and we transformed bacteria with the DpnI resistant
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obtained. We used the following primers: CPEB2 Mut92
dir and rev to generate CPEB2 Mut92; CPEB2 Mut26 dir
and rev to generate CPEB2 Mut26; CPEB3 Mut92
dir and rev to generate CPEB3 Mut92; and CPEB4
Mut92 dir and rev to generate CPEB4 Mut92
(Supplementary Table S1). We cut the inserts from pUC
using XbaI and we cloned the fragments inside the XbaI
site of the pGL3-Control vector.
To obtain a vector that over-expresses miR-26a
(pSuper-miR-26), we ampliﬁed by PCR from human
genomic DNA miR-26a precursor using hgDNA miR-26
dir and rev primers. To obtain a vector that over-expresses
miR-92a (pSuper-miR-92), we ampliﬁed by PCR from
human genomic DNA miR-92a precursor using hgDNA
miR-92 dir and rev primers. We cloned the ampliﬁcation
products inside a pSuper derived vector linearized with
BglII and HindIII.
Luciferase reporter assay
We performed Luciferase reporter assays in 24-well plates.
We co-transfected 200ng of our reporter constructs
together with 200ng of a reporter plasmid encoding for
the Renilla Luciferase in order to normalize for the
efﬁciency of transfection. We co-transfected the LNAs at
a ﬁnal concentration of 25nM (i.e. 12.5pmol in 500ml
of well volume). LNAs were purchased form Ambion.
For co-transfections with miR-26a or miR-92a encoding
vectors, we used 100ng of the reporter vector, 100ng
of the Renilla vector and 200ng of pSuper-miR-26
or pSuper-miR-92.
We harvested the cells 24h after transfection by use
of the Passive Lysis Buffer from Promega. For the dual
Luciferase reporter assay, we used the Luciferase Assay
Reagent II and the Stop & Glo Reagent from Promega.
We measured luminescence with the 20/20 Luminometer
from Turner Biosystems.
RT–qPCR of reporter constructs
We plated SK-N-BE cells in 6-well plates and 24h later we
co-transfected 2.25mg of the reporter constructs together
with 1mg of the Renilla Luciferase vector. For
co-transfections with pSuper-miR-26 or pSuper-miR-92,
we transfected 800ng of the reporter construct, 800ng of
the Renilla vector and 1.6mg of the corresponding pSuper
vector. We harvested the cells 24h after transfection and
extracted total RNA with the TRI reagent solution from
Ambion.
In order to eliminate plasmid contamination, we treated
5mg of total RNA with RNAse free DNAse from
Promega. To remove the DNAse after the reaction, we
performed an RNA extraction by using the TRI reagent
solution from Ambion. We reversed transcribed 800ng
of RNA with the M-MLV reverse transcriptase purchased
form Invitrogen.
For the qPCR, we used the following sets of primers:
Luc dir and rev to amplify the Luciferase transcript; and
Ren dir and rev to amplify the Renilla transcript, at a con-
centration of 500nM in a ﬁnal volume of 20ml. We used
the IQ Custom Syber Green Supermix 2  from
BIO-RAD. To perform the reactions, we used a C1000
Thermal Cycler / CFX96 Real time system from
Bio-Rad with the following protocol: 30s at 98 C and
40 cycles of 5s at 95.0 C and 25s at 60.0 C.
We analyzed the data with the Ct method (19) using
the Renilla cDNA to normalize for transfection efﬁciency.
Northern blot analysis for small RNAs
We prepared 13.5% (19:1) acrylamide/bisacrylamide, 5M
Urea, denaturating gels with TBE 1  buffer and loaded
10mg of total RNA. After the run, we stained the gels with
ethidium-bromide and we visualized them with a UV
trans-illuminator. We performed semi-dry transfers for
1h at 2mA/cm
2 and UV cross-linked the membrane
with 1200mJ. We used LNA oligonucleotides against
miR-92a, Let-7a and miR-9 purchased from Ambion
and a DNA oligonucleotide against miR-26a of sequence
AGCCTATCCTGGATTACTTGAA. To generate the
probes, we incubated 2pmol of the oligonucleotides with
3pmol of Adenosine 50-triphosphate [g-
32P] 3000Ci/mmol
in the presence of T4 Kinase for 1h at 37 C. We per-
formed overnight hybridizations for the LNA and the
DNA probes at 60 C and 37 C, respectively, and ﬁnally
washed the membrane at least three times with SSC 2 ,
SDS 0.1%.
Northern blot analysis of CPEB3
We prepared total RNA from SK-N-BE cells using the
TRI reagent solution from Ambion. We separated 20mg
of RNA in agarose–formaldehyde gels and proceeded
as described earlier (20,21). We prepared the probe by
PCR ampliﬁcation from human genomic DNA using the
CPEB3-A3dir and CPEB3-A3rev primers. As a marker,
we used the 0.5–1Kb RNA Ladder from Invitrogen.
30-RACE
We prepared cDNA from 1mg of total RNA from
SK-N-BE cells using Oligo dT as a primer. We performed
a ﬁrst round of PCR ampliﬁcation of the cDNA with
Anchor and CPEB3-5293Dir primers using the following
protocol: 3min at 94 C, followed by 30 cycles of, 30s
at 94 C, 30s at 56 C and 1min at 72 C, and a ﬁnal amp-
liﬁcation at 72 C for 10min. We performed a second PCR
repeating the ampliﬁcation protocol but using the ﬁrst
ampliﬁcation product as template and CPEB3-5370Dir
and Anchor primers. We run the ampliﬁcation product
in an agarose gel, cut the band and sequenced
the puriﬁed DNA.
RT–qPCR to measure the levels of the endogenous
CPEB2, CPEB3 and CPEB4 mRNAs
We ampliﬁed cDNA prepared from total RNA of differ-
ent cell lines using the following primers: GAPDH dir
and rev to amplify GAPDH cDNA; CPEB2_1096
dir and CPEB2_1178 rev to amplify CPEB2 cDNA;
CPEB3_1575 dir and CPEB3_1690 rev to amplify
CPEB3 cDNA; and CPEB4_3127 dir and CPEB4_3261
rev to amplify CPEB4 cDNA. We used GAPDH to nor-
malize the expression levels of CPEB2, CPEB3 and
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the reporter constructs.
In order to deplete the endogenous miRNAs, we plated
SK-N-BE cells in 12-well plates. We performed a ﬁrst
transfection of 25nM (i.e. 50pmol in 2ml of well
volume) of the corresponding LNAs using
Lipofectamine2000 24h after plating the cells and
repeated the same transfection 24h later. Finally, we
extracted total RNA after 24h and synthesized cDNA
using random primers. We performed the transfections
in duplicates for each treatment.
Statistical analysis
To evaluate the statistical signiﬁcance between two differ-
ent treatments, we used the Student’s t-test.
RESULTS
A novel mRNA isoform of CPEB3 is generated by
alternative polyadenylation (APA)
The transcripts of the CPEB2 subfamily members can
have 30-UTRs of more than 3.5kb [(5); Figure 1A].
Interestingly, an alignment of the human genomic se-
quences encoding for the CPEB2 subfamily transcripts
with the ortholog sequences of other vertebrates showed
a high degree of conservation along the entire 30-UTRs
sequences (Figures 1A and 2B) (22). For instance, some
regions of the human CPEB2 30-UTR showed stretches of
more than 50nt perfectly conserved in chicken. Moreover,
for CPEB2 and CPEB4 the conservation was completely
lost immediately downstream of the genomic region
encoding for the cleavage sites (CSs) of the transcripts.
However, for CPEB3 we observed a long island of con-
servation ( 950-nt long) located closely downstream of
the annotated CS (Figure 1A, empty box). To investigate
the transcriptional activity of this region, we looked
for the presence of annotated ESTs. We found a
number of tags present in this region some of them con-
taining a polyA tail not encoded in the genome and
ending  5520nt from the stop codon (Supplementary
Figure S1A and Table S2). The end of the cluster also
matched with the end of the island of conservation
(Supplementary Figures S1A and S2B). The other cluster
of ESTs that we found along the entire 30-UTR corres-
ponds to the end of the reference sequence transcript
(NM_014912, Supplementary Figure S1A and Table S2).
In order to ﬁnd cell lines expressing the CPEB2 subfam-
ily members, we performed a screening by using
semi-quantitative RT–PCR with speciﬁc primers for
each gene. All the cell lines tested expressed the three
members of the family (Supplementary Figure S3).
The expression levels were relatively low but similar
among the different subfamily members in each cell line.
Since the members of the CPEB2 subfamily have been
found in brain (2,5) and the expression levels of the
CPEB2 subfamily members in the neuroblastoma
SK-N-BE cell line were reasonably high, we selected this
cell line to perform all studies shown below (unless other-
wise stated). We investigated whether SK-N-BE cells
express the newly identiﬁed CPEB3 alternative 30-UTR
isoform by Northern blot analysis. Using a probe specif-
ic for the new region we detected a band of  7.8kb that
corresponded to the expected size of CPEB3 mRNA
polyadenylated at this novel PAS (Supplementary
Figure S1). Additionally, we performed a 30-RACE experi-
ment followed by sequencing of the PCR product that
conﬁrmed the position of the CS found analyzing the
ESTs data (Supplementary Figure S2).
Figure 1. CPEB2 subfamily members have long and conserved
30-UTRs. (A) Mapping of the last exons of human CPEB2, CPEB3
and CPEB4 transcripts to their corresponding genomic sequences
visualized with the UCSC genome browser. NCBI Reference
Sequences are NM_001177382, NM_014912 and NM_030627 for
CPEB2, CPEB3 and CPEB4 transcripts, respectively. Each window
spans 20kb of genomic sequence. The genomic coordinates of the
regions shown are chr4:15053500–15073500, chr10:93805000–
93825000 and chr5:173370000–173390000 for CPEB2, CPEB3 and
CPEB4, respectively. The coordinates correspond to the GRCh37/
hg19 assembly of the human genome. On top of each scheme exons
are depicted with boxes and introns with thin lines with arrows. The
lengths of the longest annotated 30-UTR variants are indicated above
the 30-UTRs. A conservation plot across different vertebrates is shown
for each of the CPEB2 subfamily members. The arrow on top of each
scheme indicates the direction of transcription. The empty box down-
stream of the annotated 30-UTR of CPEB3 indicates the novel 30-UTR
region. (B) Distribution of 30-UTRs according to the number of differ-
ent sequences complementary to miRNA seed sequences (conserved in
human, mouse, rat, dog and chicken) present in the 30-UTR as
determined by the TargetScanS algorithm (17). An enlargement of
the tail of the distribution is shown in the inset. The number of differ-
ent targets for CPEB2, CPEB3 and CPEB4 is indicated.
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conserved pattern of miRNA target sites in their 30-UTRs
Different groups have developed algorithms to predict
binding sites for miRNAs in the 30-UTRs of different or-
ganisms (13). John et al. (23) have suggested that CPEB2,
CPEB3 and CPEB4 mRNAs are among the transcripts
most likely to be targeted by miRNAs in vertebrates.
Here, we grouped all human 30-UTRs according
to the number of different miRNA targets predicted by
the TargetScanS algorithm (17). The distribution is shown
in Figure 1B. Consistently, the analysis of the miRNA
targets predicted with this algorithm showed that each
of the CPEB2 subfamily members has more than twenty
different recognition motifs for miRNAs. As shown
in the inset of Figure 1B, CPEB3 is encoded by one
of the six transcripts predicted to be bound by 23 different
families of miRNAs, CPEB4 transcript is one of the three
predicted to be bound by 25 different families of miRNAs
and CPEB2 is the only transcript predicted to be bound by
28 different families of miRNAs. Note that each of these
families can have one or more binding sites in each
30-UTR.
Some miRNA families are predicted to have binding
sites in more than one member of the CPEB2 subfamily
suggesting the existence of a coordinated mechanism
of regulation mediated by miRNAs. Indeed, ﬁve different
families of miRNAs (miR-9, Let-7, miR-26, miR-30 and
miR-92) were predicted to bind the three members of the
CPEB2 subfamily according to the TargetScanS algorithm
(considering miRNA recognition motifs 7- or 8-nt long).
This algorithm only considers conservation across
orthologs to identify target sites. Thus, the presence
of the same target in paralog genes could be explained
either by their conservation after the duplication of the
paralogs or by convergent evolution. For example,
miR-30 predicted binding sites are located in different pos-
itions of the 30-UTRs (Figure 2A) (i.e. close to the stop
codon in CPEB2, close to the PolyAdenylation Signal
(PAS) in CPEB3 and towards the middle in CPEB4).
Therefore, it can be suggested that these sites appeared
by convergent evolution. However, for the other four
families (miR-9, Let-7, miR-26 and miR-92), we found
that they share a common pattern of spatial distribution
in the 30-UTRs of the CPEB2 subfamily (Figure 2A), sug-
gesting that those sites were already present in the ances-
tral gene. For example, in the three members of the
subfamily we identiﬁed a putative miR-26/miR-92
doublet target sites close to the PAS. These predicted
binding motifs fall in highly conserved regions as shown
in Figure 2B for the CPEB2 miR-26/miR-92 doublet.
However, when the genomic sequences encoding for the
human paralogs were aligned the similarity between the
three members was reduced mainly to the sequences that
were predicted as putative miRNA recognition motifs
(Figure 2C). Importantly, the alignment of the three
human paralogs showed a negligible similarity along the
entire 30-UTR sequence (data not shown).
Taken together, these observations suggest that the
CPEB2 subfamily members have common predicted
miRNA-binding sites located in paralog positions of
their 30-UTRs. Most likely, this pattern was already
present in the ancestral gene before gene duplications
occurred and it was ﬁxed, in spite of the divergence
of the 30-UTRs observed now among the paralogs.
Therefore, the possible order of events regarding the
evolution of the 30-UTRs of the CPEB2 subfamily
members is: ﬁrst, the appearance of miRNA-binding
sites in the ancestral CPEB2 gene. Second, the duplication
of the paralog genes. Third, the divergence of the paralog
sequences without altering the miRNA-binding pattern
(Figures 2A and C). Fourth, the radiation of the verte-
brates and consequent emergence of ortholog genes. Fifth,
the ﬁxation of the whole 30-UTR sequences in all verte-
brates without altering the preexistent miRNA-binding
pattern (Figure 2B).
Validation of the distal miR-92 target site in the
CPEB2 context
To evaluate the hypothesis of conservation of miRNA
target sites after the duplication of the paralogs,
we focused our attention on the miR-26/miR-92 doublet,
being the targets that most clearly illustrate this possibil-
ity. In order to properly dissect the mechanism associated
only to this doublet, we studied the last region of the
30-UTRs (Figures 3A, 4A and 5A and see
Supplementary Figure S4 for a summary). In this way,
we generated reporter constructs where we cloned the
last portion of CPEB2 30-UTR downstream of the
Luciferase gene (CPEB2 WT) (Figure 3A). To evaluate
the functionality of the miR-92-binding site of the miR-
26/miR-92 doublet, we introduced point mutations to the
target motif in the reporter construct (CPEB2 Mut92). We
transfected the wild-type and miR-92 mutated constructs
into HEK293T and SK-N-BE cells since both cell lines
presented high levels of miR-92 (Supplementary
Figure S5) and evaluated the activity of both vectors by
using the dual Luciferase reporter assay. In both cell lines
the activity of the mutated construct was higher than that
of the wild-type construct (P<0.05; Figure 3B, left panel).
These results are consistent with the role of miRNAs as
negative regulators of mRNA expression.
miRNAs are known to reduce the levels of proteins
produced by their target transcripts. Although the mech-
anisms of action are not clearly resolved, in general,
miRNAs can control the levels of protein output either
by inhibiting translation or by promoting mRNA degrad-
ation (8). In order to gain further insight into the mech-
anism of regulation of CPEB2 30-UTR, we transfected
the wild-type and the miR-92 mutated constructs into
SK-N-BE cells and measured the mRNA levels of the
reporters by RT–qPCR. The level of Luciferase mRNA
was higher for the mutated species (P<0.05; Figure 3B,
right panel). These results suggest that miR-92 regulates
CPEB2 gene expression by modulating the levels
of transcript.
Next, we decided to test the effect of variations in the
levels of miRNAs on the activity of our reporter
constructs. To this end, we used two complementary
approaches. First, we depleted the endogenous miR-92
by transfecting the cells with Locked Nucleic
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sequence and, second, we over-expressed miR-92 by
transfecting the cells with a pSuper derived vector contain-
ing the genomic region encoding miR-92 precursor under
the control of the H1 promoter (pSuper-miR-92). We ﬁrst
veriﬁed by Northern blot analysis the levels of miR-92 in
the cells after the treatments (Figure 3C). Transfection
of SK-N-BE cells with the miR-92 speciﬁc LNA
Figure 2. The three members of the CPEB2 subfamily share a similar spatial distribution of common predicted miRNA targets. (A) The distribution
of binding sites corresponding to the ﬁve miRNA families that are predicted to have at least one binding site in each of the CPEB2 subfamily
transcripts is shown. Between brackets the type of predicted target and the position in the 30-UTR is shown. (7mer-1A, target complementary to a
miRNA seed sequences ﬂanked by a conserved A immediately downstream; 7mer-m8, target complementary to an extended seed sequence; 8mer,
target complementary to an extended seed sequence ﬂanked by a conserved A immediately downstream). (B) Multiple alignment of part of human,
mouse, dog and chicken CPEB2 30-UTRs obtained by using the PipMaker program (18). The nucleotide position with respect to the stop codon is
shown for humans. Conserved bases are represented with dots and indels with horizontal bars. miR-26 and miR-92 predicted targets are indicated.
(C) Alignment of the same region of the human CPEB2 30-UTR with human CPEB3 and CPEB4 30-UTRs. The nucleotide position with respect to
the stop codon is shown on the left. The predicted target motifs for miR-92 and miR-26 are shown.
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miRNA while a control LNA against miR-21 did
not affect the endogenous miR-92 levels (Figure 3C, left
panel). Transfection of the cells with pSuper-miR-92
resulted in an increase of miR-92 levels (Figure 3C,
right panel).
When we co-transfected the wild-type and mutated
CPEB2 reporter vectors together with the unspeciﬁc
LNA21, the activity of the CPEB2 Mut92 vector
was higher (Figure 3D, compare the ﬁrst and fourth
bars). However, when we co-transfected miR-92 speciﬁc
LNA with the reporter constructs, the Luciferase activity
Figure 3. Validation of the distal miR-92-binding site of CPEB2 30-UTR using reporter constructs. (A) Scheme of the reporter constructs used. The
last portion of CPEB2 30-UTR, from base 2497 onwards (with respect to the stop codon), was cloned downstream of the Luciferase gene (CPEB2
WT). Point mutations were introduced to the miR-92 target site (CPEB2 Mut92) in an analogous construct. The type and the position of the target
in the wild-type 30-UTR are indicated between brackets. (B) Left panel; relative Luciferase activity of the reporter constructs transfected into
SK-N-BE and HEK293T cells. The mean of three independent transfections is shown. Right panel; quantiﬁcation of Luciferase mRNA levels by
RT–qPCR from SK-N-BE cells transfected with the reporter constructs. CPEB2 Mut92 mRNA levels are normalized to those of CPEB2 WT. The
mean of ﬁve independent transfections is shown. (C) Left panels: Northern blot analysis for small RNAs of total RNA from SK-N-BE cells
transfected with LNAs complementary to miR-92 or miR-21. The membrane hybridized with a probe complementary to miR-92 is shown in the
upper panel. A DNA oligonucleotide with miR-92 sequence was run in parallel as a molecular weight marker (Lane 1). The same membrane, after
stripping and hybridization with a speciﬁc probe against U6, is shown in the lower panel. Right panels: Northern blot analysis for small RNAs of
total RNA from SK-N-BE cells transfected with pSuper-miR-92 or the empty vector. (D) Luciferase activity of the constructs co-transfected with
LNAs against miR-21, miR-32 or miR-92 in SK-N-BE cells. The mean of three independent transfections is shown. Values shown are relative to
CPEB2 WT activity co-transfected with the LNA against miR-21. (E) Left panel; Luciferase activity of CPEB2 WT construct co-transfected with
pSuper-miR-92. Right panel; mRNA levels of CPEB2 WT construct co-transfected with pSuper-miR-92. The mean of four independent transfections
is shown. In all cases a Renilla Luciferase expressing vector was used to normalize for the efﬁciency of transfection. The statistical signiﬁcance was
tested by using the Student’s t-test (*P<0.05, **P<0.01). Error bars indicate 1 SD.
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similar to those of the mutated one (Figure 3E, compare
the third and sixth bars). Thus, depleting the cells
of the speciﬁc miRNA or mutating its putative binding
site had similar effects on the 30-UTR-mediated regulation
of CPEB2 reporter constructs. Additionally, we used an
LNA against miR-32 that can also recognize the same
seed motif as miR-92 although their sequences are signiﬁ-
cantly different. In this case, we observed no effect of the
LNA on the Luciferase activity of the wild-type reporter
construct. These results were conﬁrmed by the
over-expression of miR-92 that resulted in a 30%
decrease of both Luciferase activity and mRNA levels
(Figure 3E). Taken together, these ﬁndings indicate that
miR-92 binds to its predicted recognition motif in the
30-UTR of CPEB2 and the observed down regulation
in protein synthesis of the CPEB2 WT reporter construct
can be attributed, at least in part, to a decrease
in the levels of transcript.
Validation of the distal miR-92 target sites in CPEB3 and
CPEB4 30-UTRs
The validation of the distal miR-92 target site in the
CPEB2 context prompted us to study its functionality
in the other paralog genes of the subfamily. To this end,
we cloned the last region of CPEB3 and CPEB4
RefSeq 30-UTRs in a reporter vector downstream of the
Luciferase gene (CPEB3 WT and CPEB4 WT respective-
ly). We also generated analogous constructs introducing
point mutations into the predicted recognition sequences
for miR-92 (CPEB3 Mut92 and CPEB4 Mut92)
(Figure 4A). Then, we transfected HEK293T and
SK-N-BE cells with the reporter vectors. In each case,
the Luciferase activity was higher for the mutated
reporter constructs (Figure 4B).
Depletion of the endogenous miR-92 with a speciﬁc
LNA produced an increase in the Luciferase activity
of the wt constructs, while no variations were observed
for the miR-92 mutant constructs (Figure 4C and E).
Supporting the previous results, over-expression
of miR-92 resulted in a decrease of Luciferase activity
for the wild-type CPEB3 and CPEB4 constructs but not
for the mutant ones (Figure 4D and F). Together, these
results suggest that the most distal miR-92 site is function-
al in all of the CPEB2 subfamily members.
Validation of miR-26 target sites in the different paralogs
Next, we wanted to investigate the functionality of the
miR-26 predicted target site located in close proximity
to the distal miR-92 motif in the CPEB2 context.
In order to increase the levels of miR-26 in neuroblastoma
cells, we adopted the same strategy used for miR-92.
We cloned the genomic region encoding miR-26 precursor
in the pSuper derived vector described above
(pSuper-miR-26). When we transfected pSuper-miR-26
into SK-N-BE cells the levels of miR-26 increased consid-
erably (Figure 5B). To evaluate the effects of miR-26
over-expression, we co-transfected pSuper-miR-26
together with CPEB2 WT. The Luciferase activity
decreased when the miRNA was over-expressed
(Figure 5C, compare the ﬁrst two bars). To validate the
speciﬁcity of the interaction, we introduced point muta-
tions into the reporter construct at the level of the miR-26
predicted target site (CPEB2 Mut26, Figure 5A). In this
case, we observed that the Luciferase activity of the
mutant construct did not change when the miRNA was
over-expressed (Figure 5C, compare the last two bars).
These results indicate that miR-26 binds to CPEB2
30-UTR at the level of the predicted target reducing
CPEB2 protein levels.
In order to gain further insight into the mechanisms
of regulation mediated by miR-26, we measured by RT–
qPCR the mRNA levels of CPEB2 WT when miR-26 was
over-expressed. We observed a decrease in the amount
of the reporter messenger when the miRNA levels
increased (Figure 5D). Thus, as with miR-92, miR-26
mediated reduction in protein output is, at least partially,
due to a decrease in the levels of Luciferase mRNA.
In summary, the results obtained using the Luciferase
reporter constructs suggest that both miR-26 and
miR-92 predicted target sites analyzed are functional
and regulate CPEB2 gene expression.
To validate the predicted miR-26-binding sites
in CPEB3 and CPEB4, we co-transfected into SK-N-BE
cells the wild-type reporter constructs together with
pSuper-miR-26. We observed a decrease in Luciferase
activity associated to the increase in miR-26 levels
in both cases (Figure 5E), as we previously observed for
the CPEB2 reporter. Thus, these results are in agreement
with the existence of functional miR-26-binding sites
in the last region of CPEB3 and CPEB4 30-UTRs.
Taken together, these observations favor a model
in which the three members of the CPEB2 subfamily;
CPEB2, CPEB3 and CPEB4, are regulated by miR-26
and miR-92. These miRNAs bind to paralog positions
of the transcripts and down-regulate their expression.
Coordinated regulation of the endogenous CPEB2,
CPEB3 and CPEB4 mRNAs by miRNAs
We have shown above that miR-92 and miR-26 are able to
regulate the expression levels of reporter genes containing
the 30-terminal portion of CPEB2, CPEB3 and CPEB4
30-UTRs. To have a deeper insight into the
miRNA-mediated regulation of the CPEB2 subfamily
of mRNAs and extend the results obtained so far to the
other families of miRNAs presumably targeting the three
paralogs, we measured the levels of the endogenous
transcripts after depleting the cells of their endogenously
expressed miRNAs. To this end, we used speciﬁc LNAs
directed against miR-92, or a mix of LNAs directed
against the four miRNA families which have predicted
binding sites in paralog positions of all three members
of the CPEB2 subfamily (Figure 2): miR-26, Let-7,
miR-9 and miR-92.
Depletion of miR-92 showed a modest (15–20%) but
signiﬁcant increase in the endogenous mRNA levels
of all three subfamily members measured by RT–qPCR
(Figure 6B) in agreement with the evolutionary analysis
and the results obtained with the reporter constructs.
Transfection of SK-N-BE cells with the LNAs mix
Nucleic Acids Research, 2010,Vol.38, No. 21 7705resulted in the almost complete depletion of miR-26a,
Let-7a, miR-9 and miR-92a (Figure 6A). The simultan-
eous depletion of miRNAs produced a more robust
increase in the levels of the transcripts ranging from
30% for CPEB3 to 45% for CPEB4, with CPEB2
showing an intermediate increase of 40% (Figure 6C).
In this way, by depleting the endogenously expressed
miRNA and measuring the levels of the endogenous
transcripts we provided further evidence that the CPEB2
subfamily members can be coordinately regulated by
a common subset of miRNAs that simultaneously recog-
nize miRNA-binding sites located in paralog positions
of their 30-UTRs
DISCUSSION
In this work, we have provided evidence that gene
expression of the CPEB2 subfamily is coordinately
regulated by a group of miRNAs. CPEB2, CPEB3 and
CPEB4 are paralog genes each one having a very high
number of predicted miRNA-binding sites in its 30-UTR
according to the TargetScanS algorithm (17). These sites
are predicted on the basis of their conservation across
ortholog genes. Therefore, target prediction is independ-
ent between paralogs for this algorithm. In this way, con-
sidering only those targets present in all three members of
the CPEB2 subfamily, we added another step of strin-
gency to our analysis. Interestingly, four out of ﬁve
Figure 4. Validation of the distal miR-92 predicted targets in paralog positions of CPEB3 and CPEB4 30-UTRs. (A) Scheme of the reporter
constructs used. The last segments of CPEB3 and CPEB4 30-UTRs, from bases 2779 and 3177 onwards, respectively (with respect to the stop
codon), were cloned downstream of the Luciferase gene (CPEB3 WT and CPEB4 WT respectively). Analogous constructs with point mutations in
the miR-92 target sequence were also generated (CPEB3 Mut92 and CPEB4 Mut92). The type and the position of the target in the wild-type
30-UTRs are indicated between brackets. (B) Relative Luciferase activity of the reporter constructs transfected into SK-N-BE and HEK293T cells.
The mean of three independent transfections is shown. (C) and (E) Luciferase activity of CPEB3 WT and CPEB4 WT (C) or CPEB3 Mut92 and
CPEB4 Mut92 reporter constructs (E) co-transfected with an LNA against miR-92a or a control LNA against miR-21. The mean of four inde-
pendent experiments is shown. (D) and (F) Luciferase activity of CPEB3 WT and CPEB4 WT (D) or CPEB2 Mut92, CPEB3 Mut92 and CPEB4
Mut92 constructs (F) co-transfected with pSuper-miR-92 or the empty vector. The mean of four independent experiments is shown. Reporter
constructs were always co-transfected with a vector encoding the Renilla Luciferase to normalize for the efﬁciency of transfection. The statistical
signiﬁcance was evaluated using the t-test (*P<0.05; **P<0.01; ***P<0.001). Error bars indicate 1 SD.
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subfamily showed a similar positional distribution
of their binding sites (miR-9, Let-7, miR-26 and miR-92,
Figure 2A). This observation strongly suggests that these
regulatory motifs were already functional in the ancestral
gene and were maintained after gene duplications in all
tetrapods. The conservation of these motifs in the three
members of the subfamily and in different species suggests
that there is a strong selective pressure on these regions.
Indeed, when the genomic sequences encoding for the
30-UTR of different orthologs were aligned the conserva-
tion was extremely high and extended to the sequences
ﬂanking the individual miRNA target sites. However,
the divergence at the sequence level of the different
paralogs suggests that the target sites were already
present before the generation of highly conserved
elements in the 30-UTRs. Interestingly, this high conserva-
tion is lost downstream of the CS in all the CPEB2 sub-
family members. This suggests that the regulatory
elements under strong evolutionary selection are part of
the mRNA itself and not of the genomic region. This
seems to be true for most conserved elements in genomic
sequences encoding for 30-UTRs (24). CPEB 30-UTR
is also conserved all throughout its sequence. However,
while the 30-UTRs of the CPEB2 subfamily members are
more than 3.5-kb long, CPEB 30-UTR is only 1390-nt
long. The CPEB transcript is also a predicted target
of miR-92, miR-9 and Let-7 suggesting a simultaneous
regulation of all the members of the family. However,
the distribution of the putative miRNA-binding sites is
different to the one observed for CPEB2, CPEB3 and
CPEB4 (data not shown).
The widespread presence of miRNAs in higher eukary-
otes suggests that they play an important role in the regu-
lation of gene expression. While in plants endogenous
small RNAs can perfectly bind and induce the cleavage
of their targets, the situation in animals is different (7).
In the latter case, the binding of the miRNA is imperfect
and changes in the target translational activity are not
always drastic. In animals, miRNAs can regulate the
Figure 5. Validation of miR-26-binding sites using reporter constructs. (A) Scheme of the reporter constructs used. The predicted miR-26 target site
in CPEB2 was mutated by site-directed mutagenesis (CPEB2 Mut26). The type and position of the target in the WT 30-UTR are indicated between
brackets. (B) Northern blot analysis for small RNAs of SK-N-BE cells transfected with pSuper-miR-26 or the empty vector. The membrane was
hybridized with a probe speciﬁc for miR-26a (upper panel). The lower panel shows the 5.8S rRNA band in the gel used as a loading control. (C)
Relative Luciferase activity of the reporter constructs co-transfected with pSuper-miR-26. The mean of three independent transfections is shown. (D)
Quantiﬁcation of Luciferase mRNA levels by RT–qPCR from SK-N-BE cells co-transfected with CPEB2 WT reporter construct and pSuper-miR-26
or the empty vector. The mean of ﬁve independent transfections is shown. Values are normalized to CPEB2 WT transcripts transfected with the
empty vector. (E) Relative Luciferase activity of CPEB3 WT and CPEB4 WT reporter constructs co-transfected with pSuper-miR-26 or the empty
vector into SK-N-BE cells. The mean of three independent transfections is shown. Reporter constructs were always co-transfected with a vector
encoding the Renilla Luciferase to normalize the efﬁciency of transfection. The statistical signiﬁcance was evaluated using the t-test (*P<0.05;
**P<0.01). The error bars indicate 1 SD.
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mechanisms such as translational repression and mRNA
degradation (8). More recently, miRNAs were also
shown to induce deadenylation of their targets (25–27).
Given the high number of predicted targets for each
miRNA it is not yet clear whether they act by affecting
the translational activity of many transcripts, or by
affecting a few key targets, or something in between.
Transcripts encoding for nucleic-acid-binding proteins
tend to be enriched in predicted targets (9). In this sense,
it is interesting to notice that the CPEB2 subfamily
members, that are suggested to be involved in
translational regulation, appeared to be particularly
regulated by miRNAs.
RNA-binding proteins are the other key players
in 30-UTR regulation. Their binding motifs are in some
cases more relaxed than those of miRNAs rendering more
difﬁcult to predict their cis-acting elements from the
30-UTR primary sequence. Many regulatory proteins
interact with sequences with high A/U content usually
referred as AU rich elements (28). Some studies have
shown that there can be a coordinated regulation
by miRNAs and RNA-binding proteins. For example,
Bhattacharyya et al. (29) have shown that CAT-1 gene
Figure 6. Co-regulation of the endogenous CPEB2, CPEB3 and CPEB4 transcripts by endogenously expressed miRNAs. (A) Total RNA samples
extracted from SK-N-BE cells transfected with a mix of LNAs against miR-92a, miR-26a, Let-7a and miR-9 (LNA Mix) or an LNA against miR-21
were run in parallel, except for the one used to detect miR-92a that corresponds to the stripped membrane used for miR-26a. The membranes were
hybridized with speciﬁc probes for the indicated miRNAs. U6 RNA was used as a loading control. (B) RT–qPCR of RNA obtained from SK-N-BE
cells transfected with an LNA against miR-92 or miR-21. The values are the average of eight or more independent experiments performed in
duplicates. (C) RT–qPCR of RNA prepared from SK-N-BE cells transfected with an LNA against miR-21 (LNA Control) or a mix of LNAs against
miR-92a, Let-7a, miR-26a or miR-9 (LNA Mix). The values are the average of four independent experiments performed in duplicates. GAPDH was
used to normalize the levels of the endogenous CPEB2, CPEB3 and CPEB4 transcripts. The statistical signiﬁcance was evaluated using the t-test
(*P<0.05; **P<0.01). The error bars represent 1 SD.
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of miR-122 and HuR. Other study has proposed that
in the germ line Dnd1 can directly interfere with
miRNA mediated regulation by competing for their
binding sites in 30-UTRs (30). In this way, particular
targets can escape inhibition mediated by co-expressed
miRNAs. In both cases, HuR and Dnd1 bind to regions
of high A/U content. The CPEB2 subfamily transcripts
have conserved A/U enriched sequences. In particular,
their 30-UTRs have conserved CPEs, as shown
in Supplementary Figure 4. Recently it has been shown
that the Xenopus laevis CPEB4 transcript is regulated by
CPEs present in its 30-UTR (31). Therefore, these mRNAs
might be bound and regulated by different proteins such
as the CPEB2 subfamily members themselves. Thus, the
steady state levels of the transcripts might not only
be determined by miRNAs but also by co-expressed
RNA-binding proteins. This could in part explain why
not always an inverse correlation between the levels
of the CPEB2 subfamily transcripts and their regulatory
miRNAs is observed across different cell lines
(Supplementary Figures S3 and S5).
MiR-26 and miR-92 families have several members and
are well conserved in vertebrates. As the Let-7 family, the
miR-92 family is also present in invertebrates. Moreover,
the octamer motif complementary to miR-92 seed
sequence has an extremely high rate of conservation in ver-
tebrates (24). Some of the miR-92 members are encoded in
three paralog clusters in the mammalian genomes (32).
Knockout mice of the three clusters show premature mor-
tality underscoring the importance of these miRNAs in
developmental control (33). Additionally, over-expression
of the cluster can lead to cancer development (12). MiR-26
has also been involved in cancer development by targeting
genes such as PTEN and EZH2 (34,35).
The prediction of miRNA targets is still under devel-
opment and different approaches, including conservation
analysis, structural studies, and functional assays are
being used and combined (36). In this study, we showed
that the conservation of predicted targets, not only in
ortholog genes, but also in paralogs could be used as an
additional tool to identify real targets. In the case of the
CPEB2 subfamily, a number of sites seem to be common
to two or three of the members. However, this might be an
exception due to the relatively long and conserved
30-UTRs of each of the CPEB2 subfamily paralogs.
Nevertheless, it could be possible that other transcripts
encoding for a group of paralog proteins, with presumably
overlapping functions, are also coordinately regulated
by one or more miRNAs.
APA can generate transcripts of different lengths where
the shorter isoforms may lack regulatory elements present
in the longer ones. In our laboratory, we have previously
shown that the b-adducin pre-mRNA can undergo APA
(37). In this gene, the usage of a proximal PAS in eryth-
roid tissues generates transcripts of approximately 3- to
4-kb long. Instead, the utilization in brain of a more distal
PAS gives rise to an unusually long mRNA of 8-kb with a
30-UTR of more than 6-kb (37). The short b adducin
transcript isoform showed a relief in gene expression due
to the loss of regulatory elements (A.F.M., unpublished
results). Recent papers provided evidence that this is a
general phenomenon associated to proliferation and is ne-
cessary to escape the tight regulation mediated by long
30-UTRs. It was shown that actively dividing cells tend
to have shorter 30-UTRs compared to differentiated cells
(38,39). Additionally, 30-UTRs shortening has been
implicated in cancer progression underscoring the import-
ance of APA from a clinical point of view (40).
However, as we showed before for b-adducin and in this
work for CPEB3, PAS are not exhaustively annotated.
Wide genome analyses of polyA sites and alternative
30-UTR isoforms strongly rely on transcriptional data
[e.g. (41,42)]. In the case of CPEB3 the striking conserva-
tion of the genomic sequence was a good enough indicator
of the existence of a novel alternative 30-UTR isoform that
was further conﬁrmed by bioinformatics and biochemical
analyses (Supplementary Figures S1 and S2). The alterna-
tive PAS is downstream of the identiﬁed miRNA targets
that co-regulate the different subfamily members.
Therefore, independently of which of these PASs is used,
the CPEB3 mRNA can be always co-regulated together
with CPEB2 and CPEB4.
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